BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 737252)

  • 1. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
    Huang LG; Bowden CL
    J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple forms of thrombocyte monoamine oxidase in patients with manic-depressive psychosis and recurrent schizophrenia].
    Smirnov AV; Prilipko LL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):76-8. PubMed ID: 3414255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase activity in schizophrenia: a review of the data.
    Wyatt RJ; Potkin SG; Murphy DL
    Am J Psychiatry; 1979 Apr; 136(4A):377-85. PubMed ID: 371419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood platelet monoamine oxidase activity in psychiatric patients.
    Friedman E; Shopsin B; Sathananthan G; Gershon S
    Am J Psychiatry; 1974 Dec; 131(12):1392-4. PubMed ID: 4432940
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
    Rihmer Z; Arató M; Bagdy G
    Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
    Meltzer HY; Zureick JL
    Psychiatry Res; 1987 Oct; 22(2):99-109. PubMed ID: 3685225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are paranoid schizophrenics biologically different from other schizophrenics?
    Potkin SG; Cannon HE; Murphy DL; Wyatt RJ
    N Engl J Med; 1978 Jan; 298(2):61-6. PubMed ID: 619236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.